7-[1-hydroxy-1-(1H-imidazol-4-yl)-3-methylbutyl]-2-methyl-1,2-dihydro-3H-benzo[e]isoindol-3-one | 430472-49-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异吲哚及其衍生物
• 英文名称: 7-[1-hydroxy-1-(1H-imidazol-4-yl)-3-methylbutyl]-2-methyl-1,2-dihydro-3H-benzo[e]isoindol-3-one
• 英文别名: 7-[1-hydroxy-1-(1H-imidazol-5-yl)-3-methylbutyl]-2-methyl-1H-benzo[e]isoindol-3-one
• CAS: 430472-49-4
• 化学式: C₂₁H₂₃N₃O₂
• 分子量: 349.433
• InChiKey: DDWSRVSFCFTHLZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  26
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  69.2
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• Imidazole derivatives, process for their preparation and their use
  申请人：——

  公开号：US20040024039A1

  公开（公告）日：2004-02-05

  The present invention provides a compound having a steroid C 17,20 -lyase inhibitory activity, which is useful as a prophylactic or therapeutic agent of prostatism and tumor such as breast cancer and the like. A compound represented by the formula: 1 wherein R is a hydrogen atom or a protecting group, R 1 is a lower alkyl group or a cyclic alkyl group, and ring A and ring B are each an optionally substituted 5-membered or 6-membered ring having an amide bond in the ring, or a salt thereof.

  本发明提供了一种具有类固醇C17,20-裂解酶抑制活性的化合物，该化合物可用作前列腺增生和乳腺癌等肿瘤的预防或治疗剂。该化合物由以下式表示：1其中R是氢原子或保护基，R1是较低的烷基或环烷基，环A和环B分别是具有环中酰胺键的可选取代的5-或6-成员环，或其盐。
• IMIDAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE
  申请人：Takeda Pharmaceutical Company Limited

  公开号：EP1344777B1

  公开（公告）日：2011-03-16
• US6960586B2
  申请人：——

  公开号：US6960586B2

  公开（公告）日：2005-11-01